Business · 1 sources covering this

Emcure Pharma surges 10%, stock hits new high on strong outlook

Analysts at Jefferies remain positive on Emcure Pharma's near- to mid-term outlook, supported by multiple growth drivers and operating-leverage benefits.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Emcure Pharma surges 10%, stock hits new high on strong outlook
Analysts at Jefferies remain positive on Emcure Pharma's near- to mid-term outlook, supported by multiple growth drivers and operating-leverage benefits.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/84d16f65b5095d8f90208c39278cd0d82db16600"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Emcure Pharma surges 10%, stock hits new high on strong outlook"></iframe>

Emcure Pharma surges 10%, stock hits new high on strong outlook

How 1 sources are covering this

Emcure Pharma surges 10%, stock hits new high on strong outlook

More from Business

Rupee rises 14 paise to 94.61 against U.S. dollar in early trade

Oil rises on Iran war uncertainty after Trump’s Republicans face election rout

Hornbill, NBCUniversal back India's EloElo in $80 mn bet on phone dramas

EPFO WhatsApp number: How to check PF balance and download passbook

Reader

Trust & legal

Across the network